The global neuromodulation devices market size was USD 3.3 Billion in 2022 and is expected to register a revenue CAGR of 9.3% during the forecast period. The steady market revenue growth can be attributed to increasing prevalence of neurological disorders, nerve injuries and respiratory conditions, growing number of geriatric population and rising adoption of clinical applications and...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian